Clinical Trial Update: Docetaxel With Bevacizumab as First-Line Therapy in Treating Women With Stage IV Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating docetaxel with bevacizumab as first-line therapy in women with stage IV breast cancer has completed with results posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• DOCETAXEL (DOCETAXEL)

Snippet

Sponsor: Translational Oncology Research International | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2016-03-29